We are live on ! Find out more
PLXP

PLx Pharma Inc. Common Stock
PLXP

Delisted

PLXP was delisted on the 12th of April, 2023.

Back to rankings

41 hedge funds and large institutions have $833K invested in PLx Pharma Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

3% more funds holding

Funds holding: 40 → 41 (+1)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

80% less capital invested

Capital invested by funds: $4.11M → $833K (-$3.28M)

Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
7
Reduced
12
Closed
11
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$84K

Top Buyers

Rank Fund Capital Flow
1
SGCA
Steel Grove Capital Advisors
Tennessee
+$332K
2
Jane Street
Jane Street
New York
+$80.6K
3
GSC
Ground Swell Capital
South Carolina
+$73.8K
4
HF
HRT Financial
New York
+$36.4K
5
VF
Virtu Financial
New York
+$29.9K

Top Sellers

Rank Fund Capital Flow
1
MP
MSD Partners
New York
-$847K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$325K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$78.4K
4
SRC
Shufro Rose & Co
New York
-$53K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$41.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
26
LPL Financial
California
$3.41K -$4.04K -9,640 -32%
MW
27
MBL Wealth
North Carolina
$3K -$3.64K -8,700 -33%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$2.58K -$78.4K -187,200 -92%
Two Sigma Investments
29
Two Sigma Investments
New York
$2.31K -$18.8K -44,920 -76%
Fayez Sarofim & Co
30
Fayez Sarofim & Co
Texas
$2.25K – – –
Goldman Sachs
31
Goldman Sachs
New York
$2.07K +$5.28K +12,620 New
Wells Fargo
32
Wells Fargo
California
$1.35K +$6 +14 +0.2%
CWM
33
Cranbrook Wealth Management
Michigan
$1.23K – – –
Osaic Holdings
34
Osaic Holdings
Arizona
$1K +$670 +1,600 +30%
BAM
35
Byrne Asset Management
New Jersey
$234 +$597 +1,427 New
LOIP
36
Live Oak Investment Partners
Texas
$4 – – –
PAG
37
Private Advisor Group
New Jersey
$2 – – –
NA
38
NewEdge Advisors
Louisiana
$1 +$1.8K +4,300 New
MP
39
MSD Partners
New York
– -$847K -1,303,800 Closed
SRC
40
Shufro Rose & Co
New York
– -$53K -82,100 Closed
Commonwealth Equity Services
41
Commonwealth Equity Services
Massachusetts
– -$32K -50,261 Closed
JMPWA
42
JP Morgan Private Wealth Advisors
California
– -$19K -29,962 Closed
Creative Planning
43
Creative Planning
Kansas
– -$16K -25,000 Closed
CC
44
Clearline Capital
New York
– -$15K -23,844 Closed
ST
45
Smithfield Trust
Pennsylvania
– -$8K -12,750 Closed
APP
46
Avantax Planning Partners
Iowa
– -$7K -10,000 Closed
Federated Hermes
47
Federated Hermes
Pennsylvania
– -$1K -743 Closed
TRCT
48
Tower Research Capital (TRC)
New York
– +$21 +50 New
Simplex Trading
49
Simplex Trading
Illinois
– +$73 +174 New
1
2

PLXP Hedge Fund Activity: Q4 2022 in Review

41 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q4 2022, worth a combined $833K — down 80% from $4.11M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new PLXP positions and 11 closed out — a net gain of 2 holders — while 7 added to existing stakes and 12 trimmed.

The largest buyer was Steel Grove Capital Advisors, adding an estimated $332K. The largest seller was MSD Partners, exiting entirely with an estimated $847K sold.

  • 41 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q4 2022, up from 40 in Q3 2022.
  • Funds reported $833K of PLx Pharma Inc. Common Stock stock for Q4 2022, down 80% quarter-over-quarter.
  • 13 funds opened new PLx Pharma Inc. Common Stock positions in Q4 2022 and 11 closed out, a net change of +2 holders.
  • The largest PLx Pharma Inc. Common Stock buyer in Q4 2022 was Steel Grove Capital Advisors, an estimated $332K added.
  • The largest PLx Pharma Inc. Common Stock seller in Q4 2022 was MSD Partners, an estimated $847K sold.

Based on aggregated 13F filings for Q4 2022.